title: Testicular cancer: current update and controversies.
abstract: Testicular cancer is an important disease affecting young men. The overall 5-year survival has improved to 95%. The goal now is to maintain the efficacy of treatment in advanced disease while reducing the associated side effects.
authors.affiliation: Institute of Urology and Nephrology, University College London, London W1W 7EY.
authors.forename: Frank
authors.initials: F
authors.lastname: Lee
authors.forename: Rizwan
authors.initials: R
authors.lastname: Hamid
authors.forename: Manit
authors.initials: M
authors.lastname: Arya
authors.forename: Hitendra R H
authors.initials: HR
authors.lastname: Patel
mesh_terms: D000465:Algorithms; D000970:Antineoplastic Agents / Q000009:adverse effects; D006801:Humans; D008197:Lymph Node Excision / Q000009:adverse effects; D008297:Male; D009367:Neoplasm Staging / Q000379:methods; D011379:Prognosis; D012307:Risk Factors; D013736:Testicular Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents